bpc 157 human clinical trial evidence safety BPC-157 and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded bpc-157 human clinical trials evidence
Description
Good candidates have chronic joint, tendon, or spine pain that has not responded fully to conservative care
The peptide protects the gut lining, reduces intestinal inflammation, and accelerates healing of damaged gut tissue
And then you have these big pharmaceutical companies going, look, they're making our drugs, they're violating our patent
discounts, fees and taxes) CJC-1295 (with DAC) is a synthetic peptide composed of a defined amino acid sequence and modified with a Drug Affinity Complex (DAC) component
